Viral vector vaccines

Viral vector vaccines

Over the past two years, the SARS-CoV-2 pandemic has highlighted the impact that emerging pathogens can have on global health. The development of new and effective vaccine technologies is vital in the fight against such threats. Viral vectors are a relatively new vaccine platform that relies on reco...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	McCann, N, O'Connor, D, Lambe, T, Pollard, AJ
Formatua:	Journal article
Hizkuntza:	English
Argitaratua:	Elseveir 2022

Antzeko izenburuak

Clinical advances in viral-vectored influenza vaccines
nork: Sebastian, S, et al.
Argitaratua: (2018)

Clinical Advances in Viral-Vectored Influenza Vaccines
nork: Sarah Sebastian, et al.
Argitaratua: (2018-05-01)

Clinical development of viral vectored vaccines against MERS-COV
nork: Ewer, K, et al.
Argitaratua: (2018)

Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen
nork: Sheerin, D, et al.
Argitaratua: (2021)

Viral vectors as vaccine platforms: from immunogenicity to impact
nork: Ewer (nee Russell), K, et al.
Argitaratua: (2016)

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults
nork: Green, C, et al.
Argitaratua: (2023)

Towards paratyphoid control: the vital role of the challenge model
nork: McCann, N, et al.
Argitaratua: (2024)

Viral vectors for malaria vaccine development.
nork: Li, S, et al.
Argitaratua: (2007)

Characterizing vaccine responses using host genomic and transcriptomic analysis.
nork: O'Connor, D, et al.
Argitaratua: (2013)

Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus
nork: Sheerin, D, et al.
Argitaratua: (2022)

Developing viral vectored vaccines for MAGE-expressing tumours
nork: McAuliffe, J
Argitaratua: (2020)

The use of viral vectors in vaccine development
nork: Tatianna Travieso, et al.
Argitaratua: (2022-07-01)

Replicon RNA Viral Vectors as Vaccines
nork: Kenneth Lundstrom
Argitaratua: (2016-11-01)

Developments in Viral Vector-Based Vaccines
nork: Takehiro Ura, et al.
Argitaratua: (2014-07-01)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
nork: Bissett, C, et al.
Argitaratua: (2024)

Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen
nork: Dylan Sheerin, et al.
Argitaratua: (2021-10-01)

Utilization of Viral Vector Vaccines in Preparing for Future Pandemics
nork: Kimberly A. Hofmeyer, et al.
Argitaratua: (2022-03-01)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
nork: Arunkumar, G, et al.
Argitaratua: (2019)

Viral vectors as vaccine platforms: Deployment in sight
nork: Rollier, C, et al.
Argitaratua: (2011)

Viral vectors as vaccine platforms: deployment in sight.
nork: Rollier, C, et al.
Argitaratua: (2011)

Viral Vectors for COVID-19 Vaccine Development
nork: Kenneth Lundstrom
Argitaratua: (2021-02-01)

Viral Vector Vaccines against Bluetongue Virus
nork: Luis Jiménez-Cabello, et al.
Argitaratua: (2020-12-01)

Novel viral vector vaccines for tropical infections
nork: Rampling, T
Argitaratua: (2017)

The use of controlled human infection models to identify correlates of protection for invasive Salmonella vaccines
nork: Naina McCann, et al.
Argitaratua: (2024-08-01)

The use of systems biology and immunological big data to guide vaccine development.
nork: Blohmke, C, et al.
Argitaratua: (2015)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
nork: McMahon, M, et al.
Argitaratua: (2019)

Pre-clinical development of viral vectored transmission-blocking malaria vaccines
nork: Kapulu, MC
Argitaratua: (2014)

RNA2HLA: HLA-based quality control of RNA-seq datasets
nork: Chelysheva, I, et al.
Argitaratua: (2021)

Vaccinating the Vulnerable: How Do We Protect Those Experiencing Homelessness?
nork: Lucy Jane McCann
Argitaratua: (2021-08-01)

Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza a virus challenge
nork: Tully, C, et al.
Argitaratua: (2017)

Research advances in replication-deficient viral vector vaccines
nork: Junna Wang, et al.
Argitaratua: (2025-03-01)

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
nork: Dulce Mata-Espinosa, et al.
Argitaratua: (2023-10-01)

Baculovirus expression vector system for production of viral vaccines /
nork: 300419 Vlak, J. M., et al.

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
nork: Marta Ulaszewska, et al.
Argitaratua: (2023-01-01)

Changes in epigenetic profiles throughout early childhood and their relationship to the response to pneumococcal vaccination
nork: Pischedda, S, et al.
Argitaratua: (2021)

Self-reported adverse events in adolescents aged 13-18 years after mass vaccination with pertussis-containing vaccine, following a school outbreak.
nork: McCann, L, et al.
Argitaratua: (2013)

Self-reported adverse events in adolescents aged 13-18 years after mass vaccination with pertussis-containing vaccine, following a school outbreak
nork: McCann, L, et al.
Argitaratua: (2013)

Searching for the human genetic factors standing in the way of universally effective vaccines.
nork: Mentzer, A, et al.
Argitaratua: (2015)

The effect of H1N1 vaccination on serum miRNA expression in children: A tale of caution for microRNA microarray studies
nork: Drury, R, et al.
Argitaratua: (2019)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
nork: Ewer (nee Russell), K, et al.
Argitaratua: (2017)